Detailed Narrative
UnBPO Strategy and Technology Arbitrage
Management highlighted the 'UnBPO' playbook as a shift from traditional labor arbitrage to technology arbitrage. By leveraging AI and automation, FSL aims to decouple revenue growth from headcount growth. Strategic investments in AppliedAI and Lyzr are central to this, enabling 'agentic AI' solutions that re-engineer workflows end-to-end, particularly in complex sectors like Mortgage and Healthcare.
Record Deal Pipeline and Large Wins
The deal pipeline hit a historic high of over $1 billion, growing at approximately 5-10% QoQ. In Q2, FSL signed four large deals (ACV >$5 million), including a major collections deal with a top UK retail bank and a claims data capture contract with a top 10 North American healthcare payer. More than 50% of the ACV from the last 22 large deals has come from non-top 5 clients, indicating successful diversification.
Geographic Divergence: North America vs. Europe
North America remains the primary growth engine, growing 16% YoY in constant currency. In contrast, Europe (specifically the UK) remains soft due to macroeconomic headwinds and regulatory-driven labor cost increases. However, management believes the transition of existing clients to offshore/nearshore locations is largely complete, and the proposed acquisition of Pastdue Credit will eventually bolster the UK utilities footprint.
Margin Expansion and Right-Shoring
Despite 90% of employees receiving annual wage hikes in Q2, EBIT margins expanded to 11.5%. This was achieved through 'right-shoring' talent—with 80% of new hires in offshore/nearshore locations—and operational efficiencies. Management expressed confidence in reaching the higher end of their 11.25-12% EBIT margin guidance for FY26, supported by a 70 bps improvement over the last four quarters.
Healthcare Vertical Momentum
The Healthcare vertical grew 6% YoY, with a pipeline that is now 2.5x larger than the previous year. FSL currently serves 12 of the top 15 health plans in the U.S. Management anticipates an accelerating growth trajectory in H2 FY26 as large deal wins from previous quarters begin to ramp up, particularly in high-complexity payer workflows driven by recent regulatory changes.